TNF and myeloid sarcoma: To this end, we exposed mature MO3.13 to a mix of the two main and well-characterized pro-inflammatory cytokines IFNγ and TNFα, causing the characteristic MS-associated neuroinflammation, alone or in combination with ERA or RLS3, and cell viability was evaluated at 18h post-treatment.